Jessica Renaux

Jessica Renaux is the Director of Clinical Operations at ImCheck Therapeutics, with responsibilities for overseeing the execution of global phase I trials in immuno-oncology since January 2024. Previously, Jessica held the same title at MaxiVAX, leading clinical trials for patient-specific cell-based anti-tumoral immunotherapy from August 2020 to December 2023. Jessica's experience includes managing a pivotal phase 3 trial at the Global Antibiotic R&D Partnership and leading clinical development at GSK, where multiple roles spanned from Clinical Development Manager to Principal Clinical Scientist, focusing on biopharmaceuticals and respiratory indications. Jessica's academic background includes a Diplome d'ingénieur in general and organic chemistry and a Master of Science in Chemistry from the University of Montpellier.